Related Experiment Video

Updated: Aug 10, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

E2F1-induced apoptosis: turning killers into therapeutics

Jens Stanelle1, Brigitte M Pützer

  • 1Department of Vectorology and Experimental Gene Therapy, University of Rostock, Schillingallee 70, 18057 Rostock, Germany.

Trends in Molecular Medicine
|March 15, 2006
PubMed

Insights

The transcription factor E2F1 acts as a tumor suppressor by initiating programmed cell death (apoptosis). Recent research explores E2F1

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Pathways

Background:

  • The cellular transcription factor E2F1 is a key component of the anti-tumorigenic safeguard mechanism.
  • E2F1 initiates programmed cell death (apoptosis) pathways, either independently or in conjunction with p53, to prevent tumor development.
  • E2F1 activation leads to downstream gene expression changes that trigger apoptosis, though precise mechanisms require further elucidation.

Purpose of the Study:

  • To review and highlight recent findings on E2F1's role in apoptosis across different cellular contexts.
  • To examine the therapeutic potential of E2F1 and its associated apoptotic pathways as drug targets.
  • To provide insights into the fundamental mechanisms of E2F1-induced apoptosis and its clinical relevance.

Main Methods:

  • Review of existing literature on E2F1 and apoptosis.
  • Analysis of recent follow-up studies investigating E2F1's role in various cellular backgrounds.
  • Exploration of therapeutic strategies targeting E2F1-induced apoptotic pathways.

Main Results:

  • E2F1 demonstrates diverse roles in programmed cell death, contingent upon the cellular environment.
  • Emerging studies utilize apoptotic E2F1 genes as novel therapeutic agents or drug targets.
  • Significant progress has been made in understanding the basic mechanisms of E2F1-mediated apoptosis.

Conclusions:

  • E2F1 is a critical regulator of apoptosis and a crucial factor in tumor suppression.
  • The therapeutic targeting of E2F1-induced apoptosis holds promise for cancer treatment.
  • Further research into E2F1's mechanisms can illuminate its clinical implications in oncology.

More Related Videos

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling08:51

Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling

Published on: June 25, 2015

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...